Assessment of Coverage, Compliance and Effectiveness of Low Dose Calcium Supplementation in BRAC Maternal, Neonatal and Child Health Programme
Fouzia Khanam, Md Belal Hossain, Sabuj Kanti Mistry and Md Mahfuzar Rahman
Hypertensive disorders are the second most common cause of maternal deaths worldwide, which caused 14% maternal death. Epidemiological and clinical studies have shown that an inverse relationship exists between calcium intake and development of hypertension in pregnancy. This study assessed the coverage, compliance of low-dose calcium as a maternal nutrition intervention during pregnancy and also the effectiveness of low-dose calcium on prevention of pregnancy induced hypertension. This cross sectional study analysed the monitoring data of 10 upazilas (sub-districts) from 4 districts where MNI initiative has been implemented. We found 78% compliance during 2nd trimester, while 71% during the 3rd trimester. We also observed that pregnant women who consumed 500mg of Calcium tablet daily for 6 months have 50% less risk of being hypertensive than who consumed less. The hypothesis can be developed from this study that one tablet (500mg@daily) is sufficient to prevent pregnancy induced hypertension.